Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Wise, David
Louw, Jessica
Krupa, Rachel
Schreiber, Nicole A.
Sawyers, Charles L.
Dittamore, Ryan Vance
Scher, Howard I.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Circulating tumor cells (CTCs) and plasma cell free DNA (cfDNA) androgen receptor amplification (ARamp)-based prognosis in metastatic castration-resistant prostate cancer (mCRPC).
    Kohli, Manish
    Li, Jian
    Du, Meijun
    Hillman, David W.
    Tan, Winston
    Carlson, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [22] Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer
    Jiang, Yuqiu
    Palma, John F.
    Agus, David B.
    Wang, Yixin
    Gross, Mitchell E.
    CLINICAL CHEMISTRY, 2010, 56 (09) : 1492 - 1495
  • [23] Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
    Lozano, Rebeca
    Lorente, David
    Aragon, Isabel M.
    Romero-Laorden, Nuria
    Nombela, Paz
    Mateo, Joaquim
    Reid, Alison H. M.
    Cendon, Ylenia
    Bianchini, Diletta
    Llacer, Casilda
    Sandhu, Shahneen K.
    Sharp, Adam
    Rescigno, Pasquale
    Garces, Teresa
    Pacheco, Maria I.
    Flohr, Penelope
    Massard, Christophe
    Lopez-Casas, Pedro P.
    Castro, Elena
    de Bono, Johann S.
    Olmos, David
    CANCERS, 2021, 13 (10)
  • [24] Prognostic value of chromogranin-a (CGA) compared to circulating tumor cells (CTCs) in metastatic castration resistant prostate cancer (mCRPC).
    Giridhar, Karthik
    Sanhueza, Cristobal T.
    Hillman, David W.
    Alkhateeb, Hassan
    Carlson, Rachel
    Tan, Winston
    Quevedo, Fernando
    Pagliaro, Lance C.
    Costello, Brian Addis
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [25] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhenchao Zhang
    Rui Luo
    William K. Kelly
    Joshua Chen
    Shane Donahue
    Kevan Ip
    Nathan R. Handley
    William J. Tester
    Miranda L. Tsang
    Felix J. Kim
    Ronald Myers
    Grace Lu-Yao
    Jian Gu
    Jianqing Lin
    Bingshan Li
    Chun Wang
    Hushan Yang
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 339 - 347
  • [26] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Vy Ngo
    Doty, Shaun
    Harris, Anna
    Winter, Michael
    Gilbert, Elizabeth
    Craik, Charles
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [27] Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).
    Friedlander, Terence W.
    Premasekharan, Gayatri
    Ngo, Vy
    Hang, Evelyn
    Graff, Julie Nicole
    Ryan, Charles J.
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
    Zhang, Zhenchao
    Luo, Rui
    Kelly, William K.
    Chen, Joshua
    Donahue, Shane
    Ip, Kevan
    Handley, Nathan R.
    Tester, William J.
    Tsang, Miranda L.
    Kim, Felix J.
    Myers, Ronald
    Lu-Yao, Grace
    Gu, Jian
    Lin, Jianqing
    Li, Bingshan
    Wang, Chun
    Yang, Hushan
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 339 - 347
  • [29] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345